Many patients with mild and non-specific clinical symptoms and reduced levels of ALP do not show specific mutations of the ALPL gene [10], so it is useful to sequence a specific panel of genes involved in bone fragility and muscle weakness for differential diagnosis of HPP using Next Generation Sequencing (NGS) techniques. The gene discussed is ALPL; the disease is hypophosphatasia.